Dataset from A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial)
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/00006893
下载链接
链接失效反馈官方服务：
资源简介：
The efficacy, safety, and dose-response of nalmefene hydrochloride at 10 mg and 20 mg in
patients with alcohol dependence will be evaluated in a multicenter, randomized,
double-blind, placebo-controlled, 3-parallel-group comparative trial. The superiority of
nalmefene hydrochloride at 20 mg to placebo will be verified in terms of reduction of alcohol
consumption.
创建时间：
2025-02-22
